Tweet
New York Times
<img alt="" height="1" width="1" />
With DeCode Deal, Amgen Aims To Discover Drugs Like We Meant To In 1999
Forbes
It certainly wasn't the deal Amgen investors were expecting from their new executive team: This morning, the Thousand Oaks, Calif., biotechnology giant dropped $415 million on DeCode Genetics, a genomics firm that Wall Streeters associate with the ...
News Summary: Amgen nabs deCODE Genetics for $415MThe Associated Press
Amgen to Acquire the Gene-Hunting Firm DeCodeNew York Times
Amgen gives VCs a deCODE double-dipFortune (blog)
San Fernando Valley Business Journal -WPXI Pittsburgh -Financial Times
all 271 news articles »
More...